A homozygous XRCC2 mutation has also been detected in a Fanconi anemia patient [9] and rare mutations in the gene in breast cancer families were identified in an exome sequencing study [10]; however, the association of XRCC2 with breast cancer risk could not be confirmed in a large follow-up study [11]. Here, XRCC2 is linked to breast carcinoma.